Biologics Contract Manufacturing Market: By Product Type, By Company Size and Region

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Biologics Contract Manufacturing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Antibodies, Cell Therapies, Vaccines, Others), By Company Size (Small, Mid-sized, Large) and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Biologics Contract Manufacturing Market size was valued at US$ 19,250.6 million in 2023 and is poised to grow at a 9.4% CAGR from 2024 to 2030. The COVID-19 epidemic in 2020 caused unparalleled growth. The main driving factors behind this expansion were the government's and major biopharmaceutical companies' increased investments aimed at boosting efficiency and productivity. Biologics outsourcing in biotechnology has emerged as a new trend. Orders and requests for biotech contract manufacturing are rising, mostly for coronavirus vaccines and treatments. More than forty queries concerning COVID-19-related projects have been received by Lonza. The supply chain is disrupted as a result of the COVID-19 epidemic.

Biologics Contract Manufacturing Market Key Developments:

  • In June 2023, Cell and Gene Therapy Catapult and Albumedix have entered into a technology licensing agreement whereby Albumedix's most recent innovations will be used to enhance the production of viral vectors.
  • In June 2023, Wuxi Biologics, which provides comprehensive solutions for the discovery, development, and production of biologics, has reported an increase in the amount of drug substances and drug products it can produce at its Wuppertal, Germany, site.

summary download arrow Download Free Sample

Biologics Contract Manufacturing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.4%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Biologics Contract Manufacturing Market Dynamics

Continuous advances in biotechnology and biomedical science approaches have significantly improved the process of developing biologics for the treatment of a variety of chronic diseases. Recent advances in biologics are targeted at improving cell line development, protein identification, expression, and engineering. Several new technologies for producing self-adjuvating antigen-adjuvant fusion protein subunit vaccines have emerged in recent years. The availability of described platforms of new adjuvants has been shown to benefit in the development of novel vaccines. Furthermore, the usage of Nano systems has grown in recent years as a means of addressing delivery problems associated with the use of mRNA therapies in disease therapy. Nonetheless, supply chains have shown to be resilient, and worldwide supplies, manufacturing, and services related to biologics have not been significantly impacted.  Several factors, including a strong pipeline of biologics, a rise in FDA NDA/BLA approvals, an increase in patent expirations, limited manufacturing capacity, and the need to realize cost savings, have led industry participants to choose contract manufacturing services for the development of biologics in order to remain competitive.

Biologics Contract Manufacturing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 19,250.6 million

Market CAGR

9.4%

By product type

  • Antibodies
  • Cell Therapies
  • Vaccines
  • Others

By Company Size

  • Small
  • Mid-sized
  • Large 

Key Features of the Report

  • The biologics contract manufacturing market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global biologics contract manufacturing market size was valued at US$ 19,250.6 million in 2023 and is projected to grow at a CAGR of 9.4% by 2030.

The rapid development of biologics has transformed the treatment of a wide range of therapeutic problems, contributing to the current exponential surge in demand for biological medicines.

The pharmaceutical industry appears to be embracing the era of biologics given the continuous advances in science and the growth of FDA-approved biologics.

Market research is segmented based on product type, company size and region.

North America is estimated to dominate with the highest CAGR over the forecast period.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Biologics Contract Manufacturing Market Introduction 
2.1.Global Biologics Contract Manufacturing Market  - Taxonomy
2.2.Global Biologics Contract Manufacturing Market  - Definitions
2.2.1.product type
2.2.2.Company Size 
2.2.3.Region
3.Global Biologics Contract Manufacturing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Biologics Contract Manufacturing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Biologics Contract Manufacturing Market  By product type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Antibodies
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Cell Therapies
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Vaccines
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Others
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
6.Global Biologics Contract Manufacturing Market  By Company Size , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Small
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Mid-sized
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Large 
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Biologics Contract Manufacturing Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Biologics Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. product type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Antibodies
8.1.2.Cell Therapies
8.1.3.Vaccines
8.1.4.Others
8.2.  Company Size  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Small
8.2.2.Mid-sized
8.2.3.Large 
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Biologics Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. product type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Antibodies
9.1.2.Cell Therapies
9.1.3.Vaccines
9.1.4.Others
9.2.  Company Size  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Small
9.2.2.Mid-sized
9.2.3.Large 
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Biologics Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. product type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Antibodies
10.1.2.Cell Therapies
10.1.3.Vaccines
10.1.4.Others
10.2.  Company Size  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Small
10.2.2.Mid-sized
10.2.3.Large 
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Biologics Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. product type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Antibodies
11.1.2.Cell Therapies
11.1.3.Vaccines
11.1.4.Others
11.2.  Company Size  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Small
11.2.2.Mid-sized
11.2.3.Large 
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Biologics Contract Manufacturing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. product type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Antibodies
12.1.2.Cell Therapies
12.1.3.Vaccines
12.1.4.Others
12.2.  Company Size  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Small
12.2.2.Mid-sized
12.2.3.Large 
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Wuxi Biologics
13.2.2.Abzena Ltd.
13.2.3.Fujifilm Inc.
13.2.4.Boehringer Ingelheim GmbH
13.2.5.Lonza
13.2.6.Vetter
13.2.7.Almac
13.2.8.Catalent
13.2.9.Reddy’s
13.2.10.Thermo Fischer (Patheon)
13.2.11.Farmar SA
14. Research Methodology 
15. Appendix and Abbreviations 

Key Market Players

  • Wuxi Biologics
  • Abzena Ltd.
  • Fujifilm Inc.
  • Boehringer Ingelheim GmbH
  • Lonza
  • Vetter
  • Almac
  • Catalent
  • Reddy’s
  • Thermo Fischer (Patheon)
  • Farmar SA

Related Industry Reports

Biologics Market

Orthobiologics Market

Global Biologics Testing Market

Global Veterinary Biologics Market